184 related articles for article (PubMed ID: 1879287)
1. [Flow cytometric DNA content analysis in thyroid carcinoma].
Zuo LF
Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):106-9. PubMed ID: 1879287
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric DNA measurement in benign and malignant human thyroid tissues.
Mizukami Y; Nonomura A; Michigishi T; Kosaka T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1992; 12(6B):2213-7. PubMed ID: 1295468
[TBL] [Abstract][Full Text] [Related]
3. [Flow cytometric DNA measurements of thyroid carcinomas].
Tsuchiya A; Sekikawa K; Kimijima I; Suzuki S; Nihei M; Rokkaku Y; Abe R
Gan No Rinsho; 1989 Jul; 35(8):886-90. PubMed ID: 2746864
[TBL] [Abstract][Full Text] [Related]
4. [Nuclear DNA in neoplastic pathology of the thyroid gland].
Sussi PL; Azzolina LS; Valerio A; Marchioretto F; Brazzarola P; Angeli G; Davì MV; Stival P; Finchi A; Francia G
Chir Ital; 1994; 46(5):74-6. PubMed ID: 7788816
[TBL] [Abstract][Full Text] [Related]
5. [Flow cytometric DNA analysis of papillary carcinoma of the thyroid using paraffin-embedded specimens].
Yamashita T; Hirayama A; Obara T; Fujimoto Y; Kodama T; Kenmotsu M; Okuda A
Gan No Rinsho; 1990 Apr; 36(5):569-73. PubMed ID: 2325263
[TBL] [Abstract][Full Text] [Related]
6. [DNA cytophotometry of oxyphilic thyroid tumors].
Pilch H; Back W; Winter J
Zentralbl Pathol; 1994 Feb; 139(6):433-6. PubMed ID: 8161492
[TBL] [Abstract][Full Text] [Related]
7. [Flow cytometry of thyroid tumors. Study of fresh tissue in 50 patients].
Suissa J; Hoang C; Soubrane C; Chigot JP; Khayat D; Leenhardt L; Aurengo A; Turpin G; Le Charpentier Y
Presse Med; 1994 Feb; 23(4):159-63. PubMed ID: 8177857
[TBL] [Abstract][Full Text] [Related]
8. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies of nuclear DNA content in benign and malignant thyroid lesions.
Konarska L; Skierski J; Ellert A; Steinbrich J; Woźniak A; Kalczak M
Acta Biochim Pol; 2001; 48(3):783-93. PubMed ID: 11833787
[TBL] [Abstract][Full Text] [Related]
10. Comparison of flow cytometric DNA content analysis of fresh and formalin-fixed paraffin-embedded solid neoplasms.
Kumar D; Kumar S; Lyon D
Mod Pathol; 1994 Apr; 7(3):354-60. PubMed ID: 8058708
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of DNA abnormalities in colorectal carcinomas.
Bocquillon PG; Daver A; Page M; Dalifard I; Chassevent A; Cellier P; Bertrand G; Larra F; George P; Chabrun B
Bull Cancer; 1989; 76(3):291-300. PubMed ID: 2736315
[TBL] [Abstract][Full Text] [Related]
12. Fetal adenomas and minimally invasive follicular carcinomas of the thyroid frequently display a triploid or near triploid DNA pattern.
Castro P; Sansonetty F; Soares P; Dias A; Sobrinho-Simões M
Virchows Arch; 2001 Apr; 438(4):336-42. PubMed ID: 11355166
[TBL] [Abstract][Full Text] [Related]
13. DNA aneuploidy in follicular adenomas of the thyroid gland.
Joensuu H; Klemi P; Eerola E
Am J Pathol; 1986 Sep; 124(3):373-6. PubMed ID: 3766698
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric DNA analysis of normal and pathologic parathyroid glands.
Harlow S; Roth SI; Bauer K; Marshall RB
Mod Pathol; 1991 May; 4(3):310-5. PubMed ID: 2068056
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of head and neck carcinoma DNA index and S-fraction from paraffin-embedded sections: comparison with malignancy grading.
Johnson TS; Williamson KD; Cramer MM; Peters LJ
Cytometry; 1985 Sep; 6(5):461-70. PubMed ID: 4042786
[TBL] [Abstract][Full Text] [Related]
16. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
Ljungberg B
Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
[TBL] [Abstract][Full Text] [Related]
17. Cytochemical assessments of the nuclear DNA distribution pattern by means of image and flow cytometry in thyroid neoplasms and in non-neoplastic thyroid lesions. A comparative methodological study.
Wallin G; Askensten U; Bäckdahl M; Grimelius L; Lundell G; Auer G
Acta Chir Scand; 1989; 155(4-5):251-8. PubMed ID: 2800873
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas.
Harlow SP; Eriksen BL; Poggensee L; Chmiel JS; Scarpelli DG; Murad T; Bauer KD
Cancer Res; 1991 May; 51(9):2403-9. PubMed ID: 2015602
[TBL] [Abstract][Full Text] [Related]
19. [Nuclear DNA content of thyroid adenocarcinoma].
Yoshida A
Nihon Geka Gakkai Zasshi; 1984 Oct; 85(10):1261-73. PubMed ID: 6503946
[TBL] [Abstract][Full Text] [Related]
20. Nuclear DNA content of the tall cell variant of papillary carcinoma of the thyroid gland.
Stern Y; Medelia O; Feinmesser M; Shpitzer T; Feinmesser R; Segal K
Ann Otol Rhinol Laryngol; 1996 Sep; 105(9):713-5. PubMed ID: 8800058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
